CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K/A Event Auditor change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- 8-K/A Event Delisting notice
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Delisting notice
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
- 8-K Event Auditor change
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
Page 55 of 68 · 1,360 filings